Abstract

BackgroundAcetamiprid (ACE) and imidacloprid (IMI) belong to a new, widely used class of pesticide, the neonicotinoids. With similar chemical structures to nicotine, neonicotinoids also share agonist activity at nicotinic acetylcholine receptors (nAChRs). Although their toxicities against insects are well established, their precise effects on mammalian nAChRs remain to be elucidated. Because of the importance of nAChRs for mammalian brain function, especially brain development, detailed investigation of the neonicotinoids is needed to protect the health of human children. We aimed to determine the effects of neonicotinoids on the nAChRs of developing mammalian neurons and compare their effects with nicotine, a neurotoxin of brain development.Methodology/Principal FindingsPrimary cultures of cerebellar neurons from neonatal rats allow for examinations of the developmental neurotoxicity of chemicals because the various stages of neurodevelopment—including proliferation, migration, differentiation, and morphological and functional maturation—can be observed in vitro. Using these cultures, an excitatory Ca2+-influx assay was employed as an indicator of neural physiological activity. Significant excitatory Ca2+ influxes were evoked by ACE, IMI, and nicotine at concentrations greater than 1 µM in small neurons in cerebellar cultures that expressed the mRNA of the α3, α4, and α7 nAChR subunits. The firing patterns, proportion of excited neurons, and peak excitatory Ca2+ influxes induced by ACE and IMI showed differences from those induced by nicotine. However, ACE and IMI had greater effects on mammalian neurons than those previously reported in binding assay studies. Furthermore, the effects of the neonicotinoids were significantly inhibited by the nAChR antagonists mecamylamine, α-bungarotoxin, and dihydro-β-erythroidine.Conclusions/SignificanceThis study is the first to show that ACE, IMI, and nicotine exert similar excitatory effects on mammalian nAChRs at concentrations greater than 1 µM. Therefore, the neonicotinoids may adversely affect human health, especially the developing brain.

Highlights

  • The neonicotinoids acetamiprid (ACE) and imidacloprid (IMI) belong to a new class of insecticides that are used worldwide to protect crops from pest insects and domestic animals from fleas [1]

  • Conclusions/Significance: This study is the first to show that ACE, IMI, and nicotine exert similar excitatory effects on mammalian nicotinic acetylcholine receptors (nAChRs) at concentrations greater than 1 mM

  • Cerebellar cultures and expression of nAChR mRNA In cerebellar cultures from neonatal rats at postnatal day 1 (P1), approximately 90% of the total cells were small neurons stained by anti-Tuj1

Read more

Summary

Introduction

The neonicotinoids acetamiprid (ACE) and imidacloprid (IMI) belong to a new class of insecticides that are used worldwide to protect crops from pest insects and domestic animals from fleas [1]. IMI and clothianidin have been reported to agonize human a4b2 nAChR subtypes [13] These findings suggest that the neonicotinoids affect mammalian nAChRs to a greater extent than previously believed based on binding-assay data and that further study of the neonicotinoids is needed to protect human health. The effects of neonicotinoids on mammalian developing neurons should be investigated and compared with those of nicotine, as a positive control that is known to affect mammalian nAChRs. Acetamiprid (ACE) and imidacloprid (IMI) belong to a new, widely used class of pesticide, the neonicotinoids. With similar chemical structures to nicotine, neonicotinoids share agonist activity at nicotinic acetylcholine receptors (nAChRs) Their toxicities against insects are well established, their precise effects on mammalian nAChRs remain to be elucidated. We aimed to determine the effects of neonicotinoids on the nAChRs of developing mammalian neurons and compare their effects with nicotine, a neurotoxin of brain development

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call